OSE Immunotherapeutics Announces Granting of First European Patent Protecting Anti-IL-7 …

17th February 2021

OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced that it has strengthened intellectual property rights for its …